|
Gary F. Blackburn, Ph.D., President and CEO, joined Ohmx from Clinical Micro Sensors, a subsidiary of Motorola, Inc. where he served as Director of Research and Technology. He has been instrumental in the development of electrochemical biosensor devices to detect nucleic acids and mutations in DNA. Previously, he served as Director of Research at IGEN International from 1987 to 1996 and Director of Technology Management at Boehringer Mannheim Diagnostics and Roche Diagnostics from 1996 to 1998. Dr. Blackburn has authored many publications in the field of diagnostic applications of chemical sensors and is the inventor on over 30 U.S. and European patents. | 